Literature DB >> 15528260

Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.

Juan He1, Matilde Inglese, Belinda S Y Li, James S Babb, Robert I Grossman, Oded Gonen.   

Abstract

PURPOSE: To quantify, with three-dimensional proton magnetic resonance (MR) spectroscopy, metabolic characteristics of normal-appearing white matter and nonenhancing lesions in patients with relapsing-remitting multiple sclerosis (MS).
MATERIALS AND METHODS: Institutional review board approval and informed patient consent were obtained. Nine patients with relapsing-remitting MS (six women, three men) and nine age-matched control subjects (seven women, two men) were studied with T1- and T2-weighted MR imaging and three-dimensional proton MR spectroscopy at spatial resolution less than a cubic centimeter. Absolute N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) levels were obtained from 171 voxels: 66 from lesions on T2-weighted MR images (43 hypointense and 23 isointense on T1-weighted MR images), 31 from normal-appearing white matter, and 74 from analogous normal white matter regions on images in control subjects.
RESULTS: Mean NAA level in hypointense lesions (5.30 mmol/L +/- 2.27 [standard deviation]) was significantly lower (P < or = .05) than that in isointense lesions (7.82 mmol/L +/- 2.28), normal-appearing white matter (7.37 mmol/L +/- 1.71), and normal white matter in control subjects (8.89 mmol/L +/- 1.54). Cho (1.79 mmol/L +/- 0.65) and Cr (5.64 mmol/L +/- 1.50) levels in isointense lesions were indistinguishable from those in normal-appearing white matter (1.74 mmol/L +/- 0.46 and 4.99 mmol/L +/- 0.97, respectively) but were significantly higher (Cho, 20%; Cr, 24%) than those in normal white matter in control subjects (1.44 mmol/L +/- 0.40 and 4.30 mmol/L +/- 1.32, respectively). NAA, Cho, and Cr levels in normal-appearing white matter were significantly different than those in normal white matter in control subjects (NAA, 20% lower; Cho, 14% higher; and Cr, 17% higher).
CONCLUSION: Abnormal metabolic activity persists in all MS tissue types. Increased Cr and Cho levels suggest (a) ongoing gliosis and attempted remyelination in isointense lesions on T1-weighted MR images and (b) membrane turnover (de- and remyelination), in addition to increased cellularity (gliosis, inflammation) in normal-appearing white matter. (c) RSNA, 2004.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528260     DOI: 10.1148/radiol.2341031895

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Authors:  Ivan I Kirov; Songtao Liu; Roman Fleysher; Lazar Fleysher; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

Review 2.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

3.  Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Authors:  Wafaa Zaaraoui; Bertrand Audoin; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  Biophys Rev       Date:  2010-04-02

4.  Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.

Authors:  M P Wattjes; G G Lutterbey; J Gieseke; F Träber; L Klotz; S Schmidt; H H Schild
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

5.  Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.

Authors:  O T Wiebenga; A M Klauser; M M Schoonheim; G J A Nagtegaal; M D Steenwijk; J A van Rossum; C H Polman; F Barkhof; P J W Pouwels; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-05       Impact factor: 3.825

Review 6.  Recent advances in the neuroimaging of multiple sclerosis.

Authors:  William D Rooney; Patricia K Coyle
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

7.  Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.

Authors:  Ivan I Kirov; Shu Liu; Assaf Tal; William E Wu; Matthew S Davitz; James S Babb; Henry Rusinek; Joseph Herbert; Oded Gonen
Journal:  Hum Brain Mapp       Date:  2017-05-19       Impact factor: 5.038

8.  Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.

Authors:  Ivan I Kirov; Assaf Tal; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Neurology       Date:  2012-11-21       Impact factor: 9.910

Review 9.  Proton magnetic resonance spectroscopy in multiple sclerosis.

Authors:  Balasrinivasa R Sajja; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

10.  Global brain metabolic quantification with whole-head proton MRS at 3 T.

Authors:  Ivan I Kirov; William E Wu; Brian J Soher; Matthew S Davitz; Jeffrey H Huang; James S Babb; Mariana Lazar; Girish Fatterpekar; Oded Gonen
Journal:  NMR Biomed       Date:  2017-07-05       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.